These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
94 related items for PubMed ID: 24354995
21. Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients. Ono A, Suzuki F, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitou S, Arase Y, Ikeda K, Kobayashi M, Watahiki S, Mineta R, Kumada H. J Hepatol; 2012 Sep; 57(3):508-14. PubMed ID: 22659518 [Abstract] [Full Text] [Related]
23. Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir. Choe WH, Hong SP, Kim BK, Ko SY, Jung YK, Kim JH, Yeon JE, Byun KS, Kim KH, Ji SI, Kim SO, Lee CH, Kwon SY. Antivir Ther; 2009 Sep; 14(7):985-93. PubMed ID: 19918102 [Abstract] [Full Text] [Related]
28. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy. Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ. Hepatology; 2009 May; 49(5):1503-14. PubMed ID: 19280622 [Abstract] [Full Text] [Related]
29. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study. Tsai MC, Chen CH, Hung CH, Lee CM, Chiu KW, Wang JH, Lu SN, Tseng PL, Chang KC, Yen YH, Hu TH. Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493 [Abstract] [Full Text] [Related]
30. Entecavir for the treatment of chronic hepatitis B infection. Shepherd J, Gospodarevskaya E, Frampton G, Cooper K. Health Technol Assess; 2009 Oct; 13 Suppl 3():31-6. PubMed ID: 19846026 [Abstract] [Full Text] [Related]
31. Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial. Yim HJ, Seo YS, Yoon EL, Kim CW, Lee CD, Park SH, Lee MS, Park CK, Chae HB, Kim MY, Baik SK, Kim YS, Kim JH, Lee JI, Lee JW, Hong SP, Um SH. Liver Int; 2013 Feb; 33(2):244-54. PubMed ID: 23295056 [Abstract] [Full Text] [Related]
32. [Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients]. Yao GB, Ren H, Xu DZ, Zhou XQ, Jia JD, Wang YM, Chen CW. Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):881-6. PubMed ID: 20038326 [Abstract] [Full Text] [Related]
33. Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance. Park JW, Kim HS, Seo DD, Jang JS, Shin WG, Kim KH, Jang MK, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK. J Viral Hepat; 2011 Oct; 18(10):e475-81. PubMed ID: 21914066 [Abstract] [Full Text] [Related]
38. [Five years trial of entecavir for chronic hepatitis B patients failed with lamivudine therapy in the Chongqing area]. LI H, WANG ZY, ZHANG DZ, SHI XF, ZHOU Z, REN H. Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):338-41. PubMed ID: 19497197 [Abstract] [Full Text] [Related]
39. Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance. Yang HJ, Lee JH, Kim YJ, Yoon JH, Lee HS. J Med Virol; 2012 Mar; 84(3):424-30. PubMed ID: 22246827 [Abstract] [Full Text] [Related]
40. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B. Lee S, Park JY, Song K, Kim DY, Kim BK, Kim SU, Ku HJ, Han KH, Ahn SH. Gut Liver; 2015 Nov 23; 9(6):776-83. PubMed ID: 25963085 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]